企業プロフィール
PepGen 株価・ニュース・カタリスト
- ティッカー:
- PEPG
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
3.14 USD (+3.46%)
終値
最終更新: 2026年8月21日
100M USD
時価総額
株価変動の要因
As of Aug 21, 2026, PEPG closed up 3.46% at $3.14. No new same-company headline was identified in the current news window.
企業概要
Oligonucleotide Delivery Company
PepGen develops Enhanced Delivery Oligonucleotides intended to transport therapeutic oligonucleotides into skeletal muscle.
PGN-EDODM1
PGN-EDODM1 is designed to correct RNA splicing in myotonic dystrophy type 1 by releasing pathogenic RNA and restoring downstream protein expression.
FREEDOM2
The FREEDOM2 study is evaluating multiple ascending doses, with early cohorts assessing safety, splice correction, and functional biomarkers.
今後のカタリスト
- Data from the fully enrolled 10 mg/kg FREEDOM2 cohort are expected in the second half of 2026.
- Data from the 12.5 mg/kg cohort are anticipated in 2027.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。